Patents by Inventor Mariel Donzeau

Mariel Donzeau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9296813
    Abstract: Antibodies and fragments that bind to the protein target Dickkopf (DKK1) are provided, as are methods of use and kits, for treating a target cell, in particular, a cell associated with an osteolytic condition.
    Type: Grant
    Filed: February 12, 2014
    Date of Patent: March 29, 2016
    Assignee: NOVARTIS AG
    Inventors: Janine R. Shulok, Feng Cong, Mark C. Fishman, Seth Ettenberg, Michael Bardroff, Mariel Donzeau, Stefanie Urlinger
  • Publication number: 20140341901
    Abstract: Antibodies and fragments that bind to the protein target Dickkopf (DKK1) are provided, as are methods of use and kits, for treating a target cell, in particular, a cell associated with an osteolytic condition.
    Type: Application
    Filed: January 24, 2014
    Publication date: November 20, 2014
    Applicant: NOVARTIS AG
    Inventors: Janine R. SHULOK, Feng CONG, Mark C. FISHMAN, Seth ETTENBERG, Michael BARDROFF, Mariel DONZEAU, Stefanie URLINGER
  • Publication number: 20140170147
    Abstract: Antibodies and fragments that bind to the protein target Dickkopf (DKK1) are provided, as are methods of use and kits, for treating a target cell, in particular, a cell associated with an osteolytic condition.
    Type: Application
    Filed: February 12, 2014
    Publication date: June 19, 2014
    Applicant: NOVARTIS AG
    Inventors: Janine R. SHULOK, Feng CONG, Mark C. FISHMAN, Seth ETTENBERG, Michael BARDROFF, Mariel DONZEAU, Stefanie URLINGER
  • Patent number: 8673306
    Abstract: Antibodies and fragments that bind to the protein target Dickkopf (DKK1) are provided, as are methods of use and kits, for treating a target cell, in particular, a cell associated with an osteolytic condition.
    Type: Grant
    Filed: January 12, 2007
    Date of Patent: March 18, 2014
    Assignee: Novartis AG
    Inventors: Janine Shulok, Feng Cong, Mark Fishman, Seth Ettenberg, Michael Bardroff, Mariel Donzeau, Stefanie Urlinger
  • Publication number: 20120023600
    Abstract: Antibodies and fragments that bind to the protein target Dickkopf (DKK1) are provided, as are methods of use and kits, for treating a target cell, in particular, a cell associated with an osteolytic condition.
    Type: Application
    Filed: January 12, 2007
    Publication date: January 26, 2012
    Inventors: Janine Shulok, Feng Cong, Mark Fishman, Seth Ettenberg, Michael Bardroff, Mariel Donzeau, Stefanie Urlinger
  • Publication number: 20070178576
    Abstract: The invention relates to a method for purifying and/or isolating high-molecular compounds, such as high-molecular proteins or protein-type compounds, contained in a solution or a suspension, by means of affinity chromatography using membranes containing metal ions.
    Type: Application
    Filed: January 27, 2005
    Publication date: August 2, 2007
    Applicants: Sartorius AG, Apanovis Biotechnologie GmbH
    Inventors: Wolfgang Demmer, Matthias Grabosch, Oscar-Werner Reif, Wolfgan Nagel, Mariel Donzeau, Peter Reichelt